Author

Matthew S. Beatty

Moffitt Cancer CenterORCID 0000-0003-3198-9264Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Shari Pilon‐ThomasiD· 2 shared Ahmed RamadaniD· 1 shared Ahmet Murat AydıniD· 1 shared Aleksandra M. KarolakiD· 1 shared Ben CreelaniD· 1 shared Brittany L. BunchiD· 1 shared Daniel Abate‐DagaiD· 1 shared Elena Martinez PlanesiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Shari Pilon‐ThomasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dual stimulation of CD40 and 41BB pathways during ex-vivo TIL expansion enhances CD8+ T cell expansion

R. A. M. Rossetti, Matthew S. Beatty, Junior Cianne, Johannes R. Ali, Kylie Harris, Ahmed Ramadan, Michael Grant, Elena Martinez Planes, Jyllica Aurelio, Lilit Karapetyan, Ben Creelan, Shari Pilon‐Thomas, Patrick Hwu, Vincent C. Luca, Daniel Abate‐Daga

This study shows that dual stimulation of CD40 and 41BB pathways using a bi-specific molecule enhances CD8+ T cell expansion in TIL cultures.

bioRxiv · Jul 26, 2026 · PreprintImmunology

PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder Cancers

Kayode D. Olumoyin, Ahmet Murat Aydın, Sarah Bazargan, Brittany L. Bunch, Ibrahim M. Chamseddine, Aleksandra M. Karolak, Matthew S. Beatty, Shari Pilon‐Thomas, Michael Adam Poch, Katarzyna Anna Rejniak

PETIL predicts TIL expansion in bladder cancer using demographic, clinical, and biological features, achieving AUC values of 0.740 and 0.857 in testing and validation cohorts.

bioRxiv · Oct 15, 2025 · PreprintImmunology